
Ibrahim D. Bori
Examiner (ID: 18672, Phone: (571)270-7020 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629 |
| Total Applications | 763 |
| Issued Applications | 313 |
| Pending Applications | 85 |
| Abandoned Applications | 385 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16613908
[patent_doc_number] => 20210032561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => FRAGRANCE COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/967911
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32776
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967911
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967911 | FRAGRANCE COMPOSITIONS AND USES THEREOF | Jul 24, 2018 | Pending |
Array
(
[id] => 16613908
[patent_doc_number] => 20210032561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => FRAGRANCE COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/967911
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32776
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967911
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967911 | FRAGRANCE COMPOSITIONS AND USES THEREOF | Jul 24, 2018 | Pending |
Array
(
[id] => 13957817
[patent_doc_number] => 20190055252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => COMPOUNDS AND METHODS FOR THE TREATMENT OF MALARIA
[patent_app_type] => utility
[patent_app_number] => 16/042827
[patent_app_country] => US
[patent_app_date] => 2018-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16042827
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/042827 | Compounds and methods for the treatment of malaria | Jul 22, 2018 | Issued |
Array
(
[id] => 13548641
[patent_doc_number] => 20180325868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => SELECTIVE OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE MODULATORS OF NR2B
[patent_app_type] => utility
[patent_app_number] => 16/042806
[patent_app_country] => US
[patent_app_date] => 2018-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16042806
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/042806 | Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B | Jul 22, 2018 | Issued |
Array
(
[id] => 13790651
[patent_doc_number] => 20190008864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING GPR119 LIGAND AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING NON-ALCOHOLIC STEATOHEPATITIS
[patent_app_type] => utility
[patent_app_number] => 16/039781
[patent_app_country] => US
[patent_app_date] => 2018-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16039781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/039781 | PHARMACEUTICAL COMPOSITION CONTAINING GPR119 LIGAND AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING NON-ALCOHOLIC STEATOHEPATITIS | Jul 18, 2018 | Abandoned |
Array
(
[id] => 13823753
[patent_doc_number] => 20190015361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => POLYTHERAPY MODULATING CATHELICIDIN GENE EXPRTESSION MODULATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/038158
[patent_app_country] => US
[patent_app_date] => 2018-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16038158
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/038158 | POLYTHERAPY MODULATING CATHELICIDIN GENE EXPRTESSION MODULATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER CONDITIONS | Jul 16, 2018 | Abandoned |
Array
(
[id] => 13577181
[patent_doc_number] => 20180340139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => INTERACTION BETWEEN QUATERNARY COMPOUNDS AND ANIONIC SURFACTANTS - FOAM ENHANCEMENT AND STABILIZATION AND PREFERRED FOAMING ANTIMICROBIAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/036535
[patent_app_country] => US
[patent_app_date] => 2018-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16036535
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/036535 | INTERACTION BETWEEN QUATERNARY COMPOUNDS AND ANIONIC SURFACTANTS - FOAM ENHANCEMENT AND STABILIZATION AND PREFERRED FOAMING ANTIMICROBIAL COMPOSITIONS | Jul 15, 2018 | Abandoned |
Array
(
[id] => 15990433
[patent_doc_number] => 20200171087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => METHODS FOR TREATING MERKEL CELL CARCINOMA (MCC) USING NK-92 CELLS
[patent_app_type] => utility
[patent_app_number] => 16/620855
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620855
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/620855 | METHODS FOR TREATING MERKEL CELL CARCINOMA (MCC) USING NK-92 CELLS | Jun 18, 2018 | Abandoned |
Array
(
[id] => 18091265
[patent_doc_number] => 20220409606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => TREATMENT OF NEURODEGENERATION VIA REPROGRAMMING METABOLISM BY INHIBITING PHD
[patent_app_type] => utility
[patent_app_number] => 16/622029
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622029
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622029 | TREATMENT OF NEURODEGENERATION VIA REPROGRAMMING METABOLISM BY INHIBITING PHD | Jun 14, 2018 | Abandoned |
Array
(
[id] => 13548659
[patent_doc_number] => 20180325877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => Use of Maleimide Derivatives for Preventing and Treating Cancer
[patent_app_type] => utility
[patent_app_number] => 16/004994
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16004994
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/004994 | Use of maleimide derivatives for preventing and treating cancer | Jun 10, 2018 | Issued |
Array
(
[id] => 13578797
[patent_doc_number] => 20180340947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => INVOLVEMENT OF THE BUFODIENOLIDES IN THE DIAGNOSIS AND TREATMENT OF POST-TRAUMATIC STRESS DISORDER (PTSD)
[patent_app_type] => utility
[patent_app_number] => 15/987039
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15987039
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/987039 | INVOLVEMENT OF THE BUFODIENOLIDES IN THE DIAGNOSIS AND TREATMENT OF POST-TRAUMATIC STRESS DISORDER (PTSD) | May 22, 2018 | Abandoned |
Array
(
[id] => 13563711
[patent_doc_number] => 20180333403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => ORGANIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/986485
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15986485
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/986485 | Organic compounds | May 21, 2018 | Issued |
Array
(
[id] => 13574805
[patent_doc_number] => 20180338951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => TREATMENTS FOR ARTERIAL STIFFENING, HYPERTENSION AND ANTI-AGING
[patent_app_type] => utility
[patent_app_number] => 15/985154
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15985154
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/985154 | TREATMENTS FOR ARTERIAL STIFFENING, HYPERTENSION AND ANTI-AGING | May 20, 2018 | Abandoned |
Array
(
[id] => 16086805
[patent_doc_number] => 20200197389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => METHODS FOR DETECTING DYSBIOSIS AND TREATING SUBJECTS WITH DYSBIOSIS
[patent_app_type] => utility
[patent_app_number] => 16/609118
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609118
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609118 | METHODS FOR DETECTING DYSBIOSIS AND TREATING SUBJECTS WITH DYSBIOSIS | May 10, 2018 | Abandoned |
Array
(
[id] => 17405998
[patent_doc_number] => 11246858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Immunoresponsive methods of treating tumors
[patent_app_type] => utility
[patent_app_number] => 15/969350
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 6581
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15969350
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/969350 | Immunoresponsive methods of treating tumors | May 1, 2018 | Issued |
Array
(
[id] => 13519405
[patent_doc_number] => 20180311245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => USE OF A COMBINATIONAL THERAPY OF LSD1 INHIBITORS WITH CDK2 INHIBITORS IN THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 15/962492
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962492
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/962492 | USE OF A COMBINATIONAL THERAPY OF LSD1 INHIBITORS WITH CDK2 INHIBITORS IN THE TREATMENT OF CANCER | Apr 24, 2018 | Abandoned |
Array
(
[id] => 13508399
[patent_doc_number] => 20180305742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => USE OF ESTROGENIC COMPOUNDS TO MANIPULATE THE BACTERIAL COMPOSITION OF VAGINAL COMMUNITIES
[patent_app_type] => utility
[patent_app_number] => 15/957686
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15957686
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/957686 | USE OF ESTROGENIC COMPOUNDS TO MANIPULATE THE BACTERIAL COMPOSITION OF VAGINAL COMMUNITIES | Apr 18, 2018 | Abandoned |
Array
(
[id] => 13456237
[patent_doc_number] => 20180279661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => COMPOSITIONS COMPRISING MEDIUM CHAIN TRIGLYCERIDES
[patent_app_type] => utility
[patent_app_number] => 15/940590
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4718
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15940590
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/940590 | COMPOSITIONS COMPRISING MEDIUM CHAIN TRIGLYCERIDES | Mar 28, 2018 | Abandoned |
Array
(
[id] => 14926395
[patent_doc_number] => 20190298835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => ADMINISTRATION OF TAILORED FEEDSTOCK TO INCREASE ANTIBIOTIC SUSCEPTIBILITY
[patent_app_type] => utility
[patent_app_number] => 15/939329
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15939329
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/939329 | ADMINISTRATION OF TAILORED FEEDSTOCK TO INCREASE ANTIBIOTIC SUSCEPTIBILITY | Mar 28, 2018 | Pending |
Array
(
[id] => 16270186
[patent_doc_number] => 20200271673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => BIOMARKER
[patent_app_type] => utility
[patent_app_number] => 16/498353
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498353
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498353 | BIOMARKER | Mar 27, 2018 | Abandoned |